biogen idec

The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session: Before The Market Opens Earnings: Affiliated Managers (NYSE: AMG) - consensus EPS $1.92 Am Superconductor (Nasdaq: AMSC) - consensus EPS $0.33 Anixter (NYSE: AXE) - consensus EPS $0.94 Archer-Daniels (NYSE: ADM)- consensus EPS $0.79 ArvinMeritor (NYSE: ARM)- consensus EPS $0.00 Autoliv (NYSE: ALV) - consensus EPS $1.71 Bemis (NYSE: BMS) - consensus EPS $0.51 Biogen Idec (Nasdaq: BIIB) - consensus EPS $1.23 BP (NYSE: BP) - consensus EPS $1.66 Celanese (NYSE: CE) - consensus EPS $0.68 Comm

The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session: Before The Market Opens Economics: 8:30am EDT

• Housing Starts - Street sees 575K
• Building Permits - Street sees 572K

Earnings: A.O.

The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session: Before The Market Opens Earnings: A.O.

Smith Corp. (NYSE: AOS) - consensus EPS $0.98 AK Steel Cotp.

The Food and Drug Administration has rejected an application to expand the use of rheumatoid arthritis treatment Rituxan for patients with earlier stages of the disease, biotech drug developers Genentech Inc. and Biogen Idec said Saturday.

Shares of Acorda Therapeutics Inc. fell Wednesday after the company gave Biogen Idec Inc. overseas rights to the experimental multiple sclerosis drug Fampridine-SR, though investors have been hoping for a buyout, according to a JPMorgan analyst.

Biogen Idec says a candidate nominated by activist shareholder Carl Icahn won a seat on the drug maker's board of directors as part of a contentious proxy fight, but the votes are still too close to call on a second seat.

Biogen Idec Inc. called a recess at its annual meeting Wednesday as activist investor Carl Icahn attempted to place dissident nominees on the board amid a contentious yearslong fight with the company.